CA
NZ
UK
AU
IND
US
Wingstop Inc. (NASDAQ:WING) released its financial results for the fiscal third quarter ended September 27, 2025, reporting total revenue of USD 175.7M, an 8.1% rise from USD 162.5M in Q3 2024. The increase was driven by higher system-wide sales and continued restaurant expansion.
Compass, Inc. (NYSE:COMP), a U.S.-based residential real estate brokerage and technology-enabled services provider, reported its financial results for the third quarter ended September 30, 2025, achieving multiple quarterly records. The company posted revenue of USD 1.85B, up 23.6% year-over-year, supported by a 21.5% rise …
U.S. equities closed higher yesterday, with several companies across technology, communications, and consumer sectors recording notable price gains. The session reflected notable attention toward firms showing positive earnings updates, business expansion, and structural demand resilience across varied industries.
Micron Technology Inc. (NASDAQ:MU) received an upgrade from Weiss Ratings. The firm raised its rating from “Hold (C+)” to “Buy (B-)” in its recent research note. The upgrade, announced on Saturday, reflects revised assessments from Weiss Ratings on the company’s financial metrics and market …
Oxford Lane Capital Corp.(NASDAQ:OXLC)released its financial results for the second fiscal quarter ended September 30, 2025, alongside the declaration of monthly distributions on common stock for the first quarter of calendar year 2026.
Milestone Pharmaceuticals Inc.NASDAQ:MISTannounced that it will present new clinical data from its investigationaletripamil nasal spray program for paroxysmal supraventricular tachycardia at the American Heart Association Scientific Sessions 2025 in New Orleans, Louisiana.
Vir Biotechnology, Inc.NASDAQ:VIRhas completed participant enrollment in ECLIPSE 1, a Phase 3 clinical study evaluating the combination of tobevibart and elebsiran for the treatment of chronic hepatitis delta.
Market Movers:On Friday, the top gainers were Rani Therapeutics Holdings, Inc. (+51.72%), followed by Cabaletta Bio, Inc. (+46.15%). On the contrary NLS Pharmaceutics Ltd. (-93.06%), and Boqii Holding Limited. (-76.43%) declined the most the same day.
Public Service Enterprise GroupNYSE:PEGreported net income of USD 622M, or USD 1.24 per share, for the quarter ended September 30, 2025, compared with USD 520M, or USD 1.04 per share, in the same period of 2024.Non-GAAP operating earnings came in at USD 565M, or …
Adaptimmune Therapeutics PLC (NASDAQ:ADAP) currently holds an average rating of“Reduce”as reported by MarketBeat Ratings. The review is based on evaluations from eight research firms.
Please wait processing your request...